17th July 2008
Fios Genomics is a new bioinformatics service in Scotland, offering an extensive portfolio of analyses.
The use of microarray technology for gene expression analysis, drug toxicity studies, biomarker discovery and SNP genotyping has increased dramatically, as well as the emergence of genomic technologies such as next generation sequencing and microRNA profiling. Such advancements in genomics technology and its increasing affordability, has led to its routine use in both academia and industry. However, as technology platforms mature the resulting data produced is becoming increasingly complex and large in volume, with current analysis methods being limited in their ability to address this. The major bottleneck is extracting the maximum information from these data. A key challenge is to link statistical know-how with bioinformatics expertise.
To address this issue, Fios Genomics offers an extensive range of genomic, advanced statistical and bioinformatic analyses services to customers based on extensive know-how in pathway and network biology, functional genomics and the analysis of microarray and other types of “omic” data. Fios Genomics can assist academic and industry research groups in the efficient mining of complex omic data. Fios Genomics has developed proprietary software solutions for the automated analyses and integration of omics datasets. Powerful network-based tools for visualisation and analysis of large datasets facilitate the manual interpretation of the assembled information in a biological context.
Fios is open to partnering opportunities with both commercial and academic organisations, or if you wish to discuss data analysis needs please visit www.fiosgenomics.co.uk for further information or contact Gary Rubin at email@example.com
Fios Genomics Ltd was founded by Professor Peter Ghazal, Dr Tom Freeman and Thorsten Forster, from the University of Edinburgh and Dr Anton Enright from the Wellcome Trust Sanger Institute, Cambridge, who combine over 50 years world-leading capability and know-how in the fields of microarray technology, genomics, bioinformatics, biostatistics, pathway biology, data visualisation and software development, a unique and unparalleled expertise in Scotland.
Dr Gary Rubin who was integral in the spin out process has joined as Director of Operations, and 2 high calibre individuals have been recruited from the Sanger Institute – Dr Al Ivens, Head of Data Analysis and Fraser Morton, Senior Software Developer.
Fios Genomics Ltd
T: +44 131 472 4800